Roche finds Genentech inflated

Roche finds Genentech inflated

Item Roche's view of the November model
Future pricing Price increases assumed in the model are optimistic given the effect of policy initiatives that may be introduced by the new U.S. administration, weak macroeconomic conditions, the ability of payers to pay for treatments, the effects of new

Read the full 543 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE